Optimization of individual and population designs using Splus
- PMID: 15000423
- DOI: 10.1023/b:jopa.0000013000.59346.9a
Optimization of individual and population designs using Splus
Abstract
We address the problem of design optimization for individual and population pharmacokinetic studies. We develop Splus generic functions for pharmacokinetic design optimization: IFIM, a function for individual design optimization similar to the ADAPT II software, and PFIM_OPT, a function for population design optimization which is an extension of the Splus function PFIM for population design evaluation. Both evaluate and optimise designs using the Simplex algorithm. IFIM optimizes the sampling times in continuous intervals of times; PFIM_OPT optimizes either, for a given group structure of the population design, only the sampling times taken in some given continuous intervals or, both the sampling times and the group structure, performing then statistical optimization. A combined variance error model can be supplied with the possibility to include parameters of the error model as parameters to be estimated. The performance of the optimization with the Simplex algorithm is demonstrated with two pharmacokinetic examples: by comparison of the optimized designs to those of the ADAPT II software for IFIM, and to those obtained using a grid search or the Fedorov-Wynn algorithm for PFIM_OPT. The influence of the variance error model on design optimization was investigated. For a given total number of samples, different group structures of a population design are compared, showing their influence on the population design efficiency. The functions IFIM and PFIM_OPT offer new efficient solutions for the increasingly important task of optimization of individual or population pharmacokinetic designs.
Similar articles
-
PFIM 4.0, an extended R program for design evaluation and optimization in nonlinear mixed-effect models.Comput Methods Programs Biomed. 2018 Mar;156:217-229. doi: 10.1016/j.cmpb.2018.01.008. Epub 2018 Jan 11. Comput Methods Programs Biomed. 2018. PMID: 29428073
-
Optimal sampling times for a drug and its metabolite using SIMCYP(®) simulations as prior information.Clin Pharmacokinet. 2013 Jan;52(1):43-57. doi: 10.1007/s40262-012-0022-9. Clin Pharmacokinet. 2013. PMID: 23212609
-
Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0.Comput Methods Programs Biomed. 2010 Apr;98(1):55-65. doi: 10.1016/j.cmpb.2009.09.012. Epub 2009 Nov 4. Comput Methods Programs Biomed. 2010. PMID: 19892427
-
Population pharmacokinetics. A regulatory perspective.Clin Pharmacokinet. 1999 Jul;37(1):41-58. doi: 10.2165/00003088-199937010-00003. Clin Pharmacokinet. 1999. PMID: 10451782 Review.
-
Design of population pharmacokinetic experiments using prior information.Xenobiotica. 2007 Oct-Nov;37(10-11):1311-30. doi: 10.1080/00498250701553315. Xenobiotica. 2007. PMID: 17968747 Review.
Cited by
-
Estimation of population pharmacokinetic parameters of saquinavir in HIV patients with the MONOLIX software.J Pharmacokinet Pharmacodyn. 2007 Apr;34(2):229-49. doi: 10.1007/s10928-006-9043-z. Epub 2007 Jan 9. J Pharmacokinet Pharmacodyn. 2007. PMID: 17211713 Free PMC article. Clinical Trial.
-
Pharmacokinetic design optimization in children and estimation of maturation parameters: example of cytochrome P450 3A4.J Pharmacokinet Pharmacodyn. 2011 Feb;38(1):25-40. doi: 10.1007/s10928-010-9173-1. Epub 2010 Nov 4. J Pharmacokinet Pharmacodyn. 2011. PMID: 21046208
-
Facilitation of drug evaluation in children by population methods and modelling.Clin Pharmacokinet. 2008;47(4):231-43. doi: 10.2165/00003088-200847040-00002. Clin Pharmacokinet. 2008. PMID: 18336053 Review.
-
Statistical power calculations for mixed pharmacokinetic study designs using a population approach.AAPS J. 2014 Sep;16(5):1110-8. doi: 10.1208/s12248-014-9641-4. Epub 2014 Jul 11. AAPS J. 2014. PMID: 25011414 Free PMC article.
-
Clinical trial simulation to evaluate power to compare the antiviral effectiveness of two hepatitis C protease inhibitors using nonlinear mixed effect models: a viral kinetic approach.BMC Med Res Methodol. 2013 Apr 25;13:60. doi: 10.1186/1471-2288-13-60. BMC Med Res Methodol. 2013. PMID: 23617810 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources